Back
Norfolk Southern Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
45
NSC
Norfolk Southern
Last Price:
$235.07
Seasonality Move:
2.53%
Sell
49
SRPT
Sarepta Therapeutics
Last Price:
$71.79
Seasonality Move:
17.94%
Sell
45
Norfolk Southern (NSC)
is a Sell
Is Norfolk Southern a Buy, Sell or Hold?
-
The current Norfolk Southern [NSC] share price is $235.76. The Score for NSC is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
NSC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $72.88. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NSC Stock Price Chart
What is Norfolk Southern's stock price today?
-
The Norfolk Southern share price today is $235.76Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NSC is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $72.88Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.
NSC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.47 | Sell |
Relative Strength Index (14 RSI): | 45.45 | Sell |
Chaikin Money Flow: | 1254895 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (232.07 - 246.37) | Sell |
Bollinger Bands (100): | (236.66 - 262.48) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -9.74 | Sell |
Relative Strength Index (14 RSI): | 28.84 | Sell |
Chaikin Money Flow: | 178900 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (82.33 - 109.07) | Sell |
Bollinger Bands (100): | (100.01 - 127.75) | Sell |
NSC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 234.28 | Buy |
20-day SMA: | 236.54 | Sell |
50-day SMA: | 245.06 | Sell |
200-day SMA: | 243.86 | Sell |
8-day EMA: | 234.55 | Buy |
20-day EMA: | 237.26 | Sell |
50-day EMA: | 242.4 | Sell |
200-day EMA: | 244.03 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 78.15 | Sell |
20-day SMA: | 92.93 | Sell |
50-day SMA: | 105.52 | Sell |
200-day SMA: | 124.39 | Sell |
8-day EMA: | 78.98 | Sell |
20-day EMA: | 89.4 | Sell |
50-day EMA: | 101.66 | Sell |
200-day EMA: | 117.08 | Sell |
Norfolk Southern Earnings Growth & NSC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.59 per share, a decrease next quarter of $0.12 per share, an increase this year of $1.26 per share, and an increase next year of $1.85 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.
Norfolk Southern Technical Analysis
Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |